Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) EBT Margin (2016 - 2025)

Iradimed (IRMD) has disclosed EBT Margin for 13 consecutive years, with 34.33% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 12662.0% to 34.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 33.84% through Dec 2025, up 3379.0% year-over-year, with the annual reading at 33.84% for FY2025, 3379.0% up from the prior year.
  • EBT Margin for Q4 2025 was 34.33% at Iradimed, roughly flat from 34.42% in the prior quarter.
  • The five-year high for EBT Margin was 38.83% in Q3 2023, with the low at 92.29% in Q4 2024.
  • Average EBT Margin over 5 years is 24.43%, with a median of 31.63% recorded in 2022.
  • The sharpest move saw EBT Margin tumbled -12485bps in 2024, then surged 12662bps in 2025.
  • Over 5 years, EBT Margin stood at 26.22% in 2021, then increased by 21bps to 31.64% in 2022, then increased by 3bps to 32.56% in 2023, then crashed by -383bps to 92.29% in 2024, then soared by 137bps to 34.33% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 34.33%, 34.42%, and 35.9% for Q4 2025, Q3 2025, and Q2 2025 respectively.